TNXP will present efficacy and safety results of TNX-102 SL (cyclobenzaprine HCl sublingual tablets), for the treatment of military-related PTSD, in a poster at the 2016 Military Health System Research Symposium being held August 15-18, 2016 in Kissimmee, FL.
Volume has been Steady as the price has gone from 2.00-2.76. Closed at 2.50 today. Presentation will be at 1pmET tomorrow Also Data coming in September for their P3 TNX-102 SL fibromyalgia. Expecting a steady climb til then.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.